ERBA Diagnostics (ERB) Posts Breakeven Q3 Loss

ERBA Diagnostics (NYSE: ERB) reported Q3 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $6.5 million versus the consensus estimate of $7.9 million.

For earnings history and earnings-related data on ERBA Diagnostics (ERB) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• zSpace, Inc. (ZSPC) Reports Q2 results